Lobradimil and Carboplatin in Treating Children With Brain Tumors
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Lobradimil may increase the effectiveness of a chemotherapy drug by
making tumor cells more sensitive to the drug.
PURPOSE: Phase II trial to study the effectiveness of carboplatin and lobradimil in treating
children with brain tumors that have not responded to previous treatment.